CLINICAL EFFICACY AND TOLERABILITY OF SAPERCONAZOLE FOR TINEA OF GLABROUS SKIN - A REPORT ON 4 CASES

In a randomized controlled trial three different treatment protocols w ith the new broad-spectrum peroral antifungal saperconazole were evalu ated. The treatment regimens were as follows: 100 mg per day for 7 day s, 200 mg per day for 7 days, 100 mg per day for 14 days. Of four asse ssable cases of dermatophytosis of glabrous skin treated with one of t hese three therapeutic regimens, one was cured. In this patient, howev er, the dermatophytosis relapsed after the end of the observation peri od, but due to a different microorganism. While partial improvement wa s seen in the other cases definite cure was not obtained. No adverse e vents were recorded.